INTRODUCTION
Spinal Cord Injury (SCI) remains a major clinical challenge because of limited therapeutic options and poor prognosis. Epigallocatechin-3-gallate (EGCG) can cross the blood-brain barrier and has demonstrated neuroprotective properties. However, its therapeutic efficacy and underlying mechanisms in SCI rema...
Jia-Lu Wen, Ai-Fang Zhou, Yun-Shi Xiao et al.· Current Neuropharmacology· 0 citations
BACKGROUND
Cervical spondylotic myelopathy (CSM) involves progressive neurological dysfunction often linked to mitochondrial impairment. Mitophagy, a selective autophagic process, is crucial for neuronal homeostasis; however, its role in CSM and the specific involvement of AMPK subunits in TFEB-mediated mitophagy remai...
Pei-Min Pu, Yu-Xiang Dai, Shi-Pian Li et al.· Phytomedicine· 0 citations
Findings suggest that MSN‐BO@LUT not only provides a developed, safe, effective nanotherapeutic strategy for SCI treatment but also serves as a translatable template for developing precision nanomedicines targeting CNS disorders.
Yi-Xuan Wang, Bo Jin, Shi-Pian Li et al.· Advancement of science· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.